Mokrý Jaroslav, Ehrmann Jirí, Karbanová Jana, Cízková Dana, Soukup Tomás, Suchánek Jakub, Filip Stanislav, Kolár Zdenĕk
Charles University in Prague, Faculty of Medicine and University Hospital Hradec Králové, Department of Histology and Embryology, Czech Republic.
Acta Medica (Hradec Kralove). 2008;51(3):173-9. doi: 10.14712/18059694.2017.20.
Our previous findings performed in rat tissues demonstrated that intermediate filament nestin is expressed in endothelial cells of newly formed blood vessels of developing organs and neural transplants. The aim of the present study was to identify other cellular markers expressed in nestin-positive (nestin+) blood vessels. To reach this goal we performed double immunofluorescent study to co-localize nestin with endothelium-specific markers (CD31, CD34 II, vimentin) or markers of perivascular cells (GFAP, SMA) in paraffin-embedded sections of normal human brain tissue, low- and high-grade gliomas, postinfarcted heart and samples of non-neural tumours. Our findings documented that all the samples examined contained blood vessels with different ratio of nestin+ endothelial cells. Double immunostaining provided unambiguous evidence that endothelial cells expressed nestin and allowed them to distinguish from other nestin+ elements (perivascular astrocytic endfeet, undifferentiated tumour cells, smooth muscle cells and pericytes). Nestin+ endothelium was not confined only to newly formed capillaries but was also observed in blood vessels of larger calibres, frequently in arterioles and venules. We conclude that nestin represents a reliable vascular marker that is expressed in endothelial cells. Elevation of nestin expression likely corresponds to reorganization of intermediate filament network in the cytoskeleton of endothelial cells in the course of their maturation or adaptation to changes in growing tissues.
我们之前在大鼠组织中进行的研究结果表明,中间丝巢蛋白在发育器官和神经移植中新形成血管的内皮细胞中表达。本研究的目的是确定在巢蛋白阳性(nestin+)血管中表达的其他细胞标志物。为了实现这一目标,我们进行了双重免疫荧光研究,以在正常人脑组织、低级别和高级别胶质瘤、心肌梗死后心脏以及非神经肿瘤样本的石蜡包埋切片中,将巢蛋白与内皮细胞特异性标志物(CD31、CD34 II、波形蛋白)或血管周围细胞标志物(胶质纤维酸性蛋白、平滑肌肌动蛋白)进行共定位。我们的研究结果表明,所有检测样本均含有不同比例的巢蛋白+内皮细胞的血管。双重免疫染色提供了明确的证据,证明内皮细胞表达巢蛋白,并使其能够与其他巢蛋白+成分(血管周围星形胶质细胞终足、未分化肿瘤细胞、平滑肌细胞和周细胞)区分开来。巢蛋白+内皮细胞不仅局限于新形成的毛细血管,在较大口径的血管中也有观察到,常见于小动脉和小静脉。我们得出结论,巢蛋白是一种在内皮细胞中表达的可靠血管标志物。巢蛋白表达的升高可能与内皮细胞在成熟过程中或适应生长组织变化时细胞骨架中间丝网络的重组相对应。